Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound
Dibya Ghimire, Chloe M. Hasund, John Bianchi Colangeli, May Yee Liew, Emory Abar, Mamadou Barry, Andrew Alexandrescu, Benjamin L. Kotzen, Zahra Reynolds, Eliza Passell, Chase B. Mandell, Zoie Smith-Sparks, Karry Su, Julie Boucau, Owen T. Glover, , Jacob E. Lemieux
This study examines immune responses in adults with COVID-19 who received or did not receive nirmatrelvir-ritonavir, finding no differences in immune markers between those with and without virologic rebound.
bioRxiv · Jun 23, 2026 · PreprintImmunology